Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.92 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.92 |
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709905 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL1878915 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL30196964 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL886884 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL1878226 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL28565592 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL11091323 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL1880424 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL22400853 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL16230482 | 1.00 | FFAR4 (0.92) | FFAR4FFAR1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240191129-A1 | WATER-BASED FRICTION-REDUCING SLURRY COMPOSITIONS, FORMATION TREATING FLUIDS THEREFROM, AND METHOD FOR MAKING AND USING SAME | PfP Industries LLC (US) | 2024-06-13 | — | — | US | claimed |
| US-20250034959-A1 | APPARATUSES AND SYSTEMS FOR IN-LINE WATER ANALYSIS, DOWNHOLE FLUID OPTIMIZATION, AND METHODS FOR MAKING AND USING SAME | PfP Industries LLC (US) | 2025-01-30 | — | — | US | disclosed |
| US-20250035527-A1 | MODELING OPTIMIZED FRICTION REDUCING COMPOSITIONS FOR DOWNHOLE FLUID COMPOSITIONS AND METHODS OF MAKING AND USING | PfP Industries LLC (US) | 2025-01-30 | — | — | US | disclosed |
| US-20240191129-A1 | WATER-BASED FRICTION-REDUCING SLURRY COMPOSITIONS, FORMATION TREATING FLUIDS THEREFROM, AND METHOD FOR MAKING AND USING SAME | PfP Industries LLC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20230398132-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | GREENWOOD BRANDS, LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-11771708-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | GREENWOOD BRANDS, LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-11648257-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | PLX OPCO INC. (US) | 2023-05-16 | — | — | US | disclosed |
| EP-4125820-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF PH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | PLx Opco Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-115666523-A | Drug carriers capable of pH dependent reconstitution and methods of making and using the same | PLX 奥普科有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20220168321-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | PLX OPCO INC. (US) | 2022-06-02 | — | — | US | disclosed |
| US-9028829-B2 | Uniform field magnetization and targeting of therapeutic formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2015-05-12 | — | — | US | disclosed |
| US-20140170201-A1 | UNIFORM FIELD MAGNETIZATION AND TARGETING OF THERAPEUTIC FORMULATIONS | DREXEL UNIVERSITY (US) | 2014-06-19 | — | — | US | disclosed |
| US-8562505-B2 | Uniform field magnetization and targeting of therapeutic formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2013-10-22 | — | — | US | disclosed |
| US-20130156792-A9 | Uniform field magnetization and targeting of therapeutic formulations | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-06-20 | — | — | US | disclosed |
| US-20130096361-A9 | Uniform field magnetization and targeting of therapeutic formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2013-04-18 | — | — | US | disclosed |
| US-20130011370-A1 | Uniform Field Magnetization and Targeting of Therapeutic Formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2013-01-10 | — | — | US | disclosed |
| EP-2512512-A1 | UNIFORM FIELD MAGNETIZATION AND TARGETING OF THERAPEUTIC FORMULATIONS | The Children's Hospital of Philadelphia (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011075255-A1 | UNIFORM FIELD MAGNETIZATION AND TARGETING OF THERAPEUTIC FORMULATIONS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20100260780-A1 | Uniform field magnetization and targeting of therapeutic formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2010-10-14 | — | — | US | disclosed |
| US-20090082611-A1 | Uniform field magnetization and targeting of therapeutic formulations | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220168321-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | ABCB11, SLC47A1, SLC46A1 | FFAR4 1765/4885FFAR1 1292/4885GPR84 1772/4885 |
| US-20230398132-A1 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | ABCB11, SLC47A1, SLC46A1 | FFAR4 1765/4885FFAR1 1292/4885GPR84 1772/4885 |
| US-11648257-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | ABCB11, SLC47A1, SLC46A1 | FFAR4 1765/4885FFAR1 1292/4885GPR84 1772/4885 |
| US-11771708-B2 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | ABCB11, SLC47A1, SLC46A1 | FFAR4 1765/4885FFAR1 1292/4885GPR84 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.